Novartis’ IL-17 inhibitor Cosentyx has become the first new biological therapy for the painful skin condition hidradenitis suppurativa (HS) in nearly a decade, following its approval by the European ...
Heartseed Inc. and Novo Nordisk - in partnership since June 2021 - have announced that the first patient has been successfully dosed in a clinical study with HS-001, a cell therapy designed to restore ...
A look at the Los Angeles Times’ 10-member All-Star girls’ basketball team for the 2025-26 season. A look at the Los Angeles Times’ 10-member All-Star boys’ basketball team for the 2025-26 season.
Hidradenitis suppurativa (HS) is staged as mild, moderate, or severe using the Hurley system. It develops when hairs and bacteria get trapped in follicles, triggering inflammation. Hurley stage 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results